Therapeutic Asset Ratings
3,272 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Nivolumab
Keratoacanthoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Squamous Cell Carcinoma Of The Small Intestine
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Spindle Cell Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Hypopharyngeal Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Laryngeal Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Vulvar Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Sweat Gland Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Teratoma With Malignant Transformation
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Testicular Non-Seminomatous Germ Cell Tumor
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Tracheal Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Transitional Cell Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Bladder Urachal Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Ureter Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Ureter Squamous Cell Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Urethra Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Urethra Clear Cell Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Urethra Squamous Cell Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Vaginal Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Vaginal Melanoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Vaginal Squamous Cell Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Vulvar Melanoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nivolumab
Vulvar Squamous Cell Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Nogapendekin Alfa
Colorectal Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Nogapendekin Alfa
Lynch Syndrome
National Cancer Institute (NCI)
P2
CCC
(53)
Showing 1801 to 1825 of 3,272 assets
Previous
Page 73 of 131
Next